Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Free Cash Flow (2018 - 2025)

Viemed Healthcare's Free Cash Flow history spans 8 years, with the latest figure at $23.2 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 635.12% year-over-year to $23.2 million; the TTM value through Dec 2025 reached $51.9 million, up 3839.0%, while the annual FY2025 figure was $51.9 million, 3839.0% up from the prior year.
  • Free Cash Flow reached $23.2 million in Q4 2025 per VMD's latest filing, up from $17.5 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $23.2 million in Q4 2025 to a low of -$12.8 million in Q4 2023.
  • Average Free Cash Flow over 5 years is $5.1 million, with a median of $3.2 million recorded in 2022.
  • Peak YoY movement for Free Cash Flow: crashed 856.29% in 2021, then surged 906.77% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at $2.0 million in 2021, then surged by 285.74% to $7.7 million in 2022, then tumbled by 266.61% to -$12.8 million in 2023, then skyrocketed by 124.67% to $3.2 million in 2024, then skyrocketed by 635.12% to $23.2 million in 2025.
  • Per Business Quant, the three most recent readings for VMD's Free Cash Flow are $23.2 million (Q4 2025), $17.5 million (Q3 2025), and $11.9 million (Q2 2025).